Acumen’s $130 Million Common Stock Public Offering

Pietro Martinoia North America Legal Chronicle
Tagged:

Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters.Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of 16,774,193…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here